Showing results (21-30 of 233) with videos related to
Sort By:
Pageof 24
Revue Des Maladies Respiratoires|December 25, 2009
[Towards a histologically guided management for NSCLC]G Milano, J Bennouna, D PlanchardAnnals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2015
High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancerE Pailler, N Auger, C R Lindsay, et al.Bulletin Du Cancer|May 9, 2009
[Malnutrition in cancer patient: when to have a specialized consultation?]S Antoun, V BaracosEuropean Journal of Cancer (Oxford, England : 1990)|November 29, 2017
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteriaM Tazdait, L Mezquita, J Lahmar, et al.Revue De Pneumologie Clinique|July 23, 2011
[What is the best sequence of treatment for patients with EGFR mutations?]B Besse, G ZalcmanAnnals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Maintenance strategies in stage IV non-small-cell lung cancer (NSCLC): in which patients, with which drugs?V Polo, B BesseRevue Des Maladies Respiratoires|February 24, 2015
[Targeted therapies in non-small cell lung cancer in 2014]C Leduc, B BesseBulletin Du Cancer|July 28, 2010
[Internet as a tool in oncology: critical analysis]B Rousseau, B Besse, Lung Cancer (Amsterdam, Netherlands)|January 21, 2014
Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?M Macerelli, C Caramella, L Faivre, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 20, 2006
Heated intra-operative intraperitoneal oxaliplatin alone and in combination with intraperitoneal irinotecan: Pharmacologic studiesD Elias, B Raynard, M Bonnay, et al.Pageof 24